RxDoctor Payments Data

Oscar Rojas, DPM

Foot & Ankle Surgery · Delray Beach, FLNPI 1669001152

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,993 of the $7,596 with a category attached, or 65.7%. 23 manufacturers reported payments, led by Stryker at 26.9% of the total. Reporting peaked in 2024 at $2,874 and has fallen 53.5% since, to $1,337 in 2025.

$7,596in general payments, 2019–2025

Across 89 payments — averaging $85.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Musculoskeletal Transplant Foundation Inc.$2K
  • Integra Lifesciences Corporation$884
  • Triad Life Sciences Inc.$415
  • Next Science LLC$395
  • Smith+Nephew$306
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$75010%
  • Travel & lodging$99813%
  • Food & beverage$4,99366%
  • Other$85511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,596 in reported general payments places this provider in the 70th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$844,028
Medicare patients
208
Services billed
4,831

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin38$234

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Delray Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →